SOPHiA GENETICS Q4 Earnings Call Highlights [Yahoo! Finance]
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: Yahoo! Finance
ex-biopharma +31%), added 124 new customers in 2025 (102 implemented), and saw average contract value for 2025 signings rise , including large U.S. health systems expected to support genomic testing for up to 60,000 patients annually Platform scale and tech edge: The SOPHiA DDM platform analyzed over 391,000 patients in 2025 (about 30,000/month across 75 countries), processed nearly 1 PB of genomic data, and offers next-gen capacity (adopted by ~1/3 of customers) that can run a whole-genome analysis in under six hours Financial outlook and leadership transition: Management guided 2026 revenue of $92–94M (20–22% growth) and an improved adjusted EBITDA loss of $29–32M with a path to breakeven by end-2026 and positive adjusted EBITDA in H2 2027, while naming Ross Muken as CEO effective July 1 as co-founder Jurgi Camblong shifts to Executive Chairman. Interested in SOPHiA GENETICS SA? Here are five stocks we like better. SOPHiA GENETICS (NASDAQ:SOPH) executives highlighted acceler
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS (SOPH) had its "buy" rating reaffirmed by BTIG Research.MarketBeat
- SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- SOPHiA Genetics GAAP EPS of -$0.28 misses by $0.02, revenue of $21.7M beats by $0.81M [Seeking Alpha]Seeking Alpha
SOPH
Earnings
- 5/6/25 - Miss
SOPH
Sec Filings
- 3/3/26 - Form F-3
- 3/3/26 - Form 20-F
- 3/3/26 - Form 6-K
- SOPH's page on the SEC website